Gene: DAGLA
Official Full Name: diacylglycerol lipase alphaprovided by HGNC
Gene Summary: This gene encodes a diacylglycerol lipase. The encoded enzyme is involved in the biosynthesis of the endocannabinoid 2-arachidonoyl-glycerol.[provided by RefSeq, Nov 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38730 | DAGLA Knockout cell line (HeLa) | Human | DAGLA | 1:3~1:6 | Negative | Online Inquiry |
KO38731 | DAGLA Knockout cell line (HCT 116) | Human | DAGLA | 1:2~1:4 | Negative | Online Inquiry |
KO38732 | DAGLA Knockout cell line (HEK293) | Human | DAGLA | 1:3~1:6 | Negative | Online Inquiry |
KO38733 | DAGLA Knockout cell line (A549) | Human | DAGLA | 1:3~1:4 | Negative | Online Inquiry |
DAGLA Gene Knockout Cell Lines represent a significant advancement in the field of genomics and molecular biology, specifically designed to facilitate the study of diacylglycerol lipase alpha (DAGLA) functions and its role in lipid metabolism. Developed through precise genomic editing techniques, these cell lines effectively disrupt the expression of the DAGLA gene, allowing researchers to investigate the physiological and pathological implications of its absence.
The primary mechanism by which DAGLA gene knockout operates is through CRISPR-Cas9 technology, which enables targeted modifications to the genome. This process results in the generation of cell lines that can be used to assess the downstream effects of DAGLA depletion on various cellular pathways, particularly those involved in endocannabinoid signaling and lipid synthesis. By providing insights into the biological roles of DAGLA, these knockout cell lines are invaluable tools for elucidating the molecular mechanisms underlying various diseases, including metabolic disorders, neurodegenerative diseases, and cancer.
From a scientific perspective, DAGLA Gene Knockout Cell Lines are indispensable in both research and clinical settings, enabling the validation of hypotheses related to lipid signaling pathways. They possess notable advantages over traditional experimental models, including enhanced specificity and reproducibility, as well as the ability to create cell-type specific models that better mimic in vivo conditions. Unlike other methods that may lead to off-target effects or incomplete gene knockouts, the precision afforded by CRISPR-Cas9 ensures a more refined and reliable approach to gene function analysis.
For researchers and clinicians aiming to explore the intricate roles of lipases in cellular homeostasis and therapeutic interventions, these knockout cell lines provide an unmatched resource. By leveraging these innovative models, the potential for discovering novel targets for drug development is significantly enhanced.
Unleashing the power of this technology, our company stands at the forefront of biological solutions, equipping researchers with high-quality tools that empower them to unravel complex biological questions with confidence and clarity.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.